Metabolic associated fatty liver disease increases risk of adverse events after acute coronary syndrome.

Back

ESC Professional Premium Access

Metabolic associated fatty liver disease increases risk of adverse events after acute coronary syndrome.

Session: What defines risk in acute coronary syndromes

Topic: Clinical

Speaker: Doctor N. Chew (Singapore, SG)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Doctor Nicholas Chew

National University Health System, Singapore (Singapore)

0 follower

5 more presentations in this session

Bleeding risk in patients hospitalized for non-ST-segment elevation acute coronary syndromes in Switzerland: performance of the CRUSADE score

Speaker: Doctor F. Wenzl (Zurich, CH)

Clinical risk scores versus simple integrated clinical judgment in patients with suspected acute coronary syndromes

Speaker: Doctor J. Boeddinghaus (Edinburgh, GB)

Sex inequities in the performance of the GRACE 2.0 score in non-ST-segment elevation acute coronary syndromes: a multinational observational study in contemporary cohorts from four European countries

Speaker: Doctor F. Wenzl (Zurich, CH)

Long-term non-cardiovascular morbidity risk remains elevated following myocardial infarction: a nationwide cohort study

Speaker: Doctor D. Christensen (Roskilde, DK)

Association of ischemic and bleeding events with mortality in patients with a recent acute myocardial infarction

Speaker: Ms M. Simonsson (Stockholm, SE)

Access the full session

What defines risk in acute coronary syndromes

Speakers: Doctor N. Chew, Doctor F. Wenzl, Doctor J. Boeddinghaus, Doctor F. Wenzl, Doctor D. Christensen...

Access

Video

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources